65,437 trials
Posttraumatic Stress Disorder · Depression
Primary: Change Clinical-Administered Post Traumatic - DSM-5 — -9.4; -10.9 score on a scale
Schizophrenia
Primary: Positive and Negative Symptom Improvement — 41.3; 40.3; 36.6; 37.3 score on a scale
Pain, Postoperative
Primary: Average Change From Baseline for Pain Intensity at Rest Over Days 1 to 3 (Etoricoxib vs. Placebo) — -3.93; -3.87; -3.39 Score on a scale — p=0.018
Stem Cell Transplantation · Leukemia · Lymphoma
Primary: Number of Participants With Survival Rate at 100 Days Post-transplant — 45 Participants
Migraine
Primary: Change in Headache Severity. — 0.81; 0.97 units on a scale
Cataract
Primary: Monocular Photopic Distance Corrected Intermediate Visual Acuity (DCIVA) [(Logarithm of the Minimum Angle of Resolution (logMAR)] 66 Centimeters (cm) From Spectacle…
Subscapularis Peel · Morselized Osteotomy
Primary: Subscapularis Strength — 4.4; 5.5 kg
Diabetes · Kidney Diseases
Primary: Mean Glucose Concentration Measured by CGM — 151.5 mg/dL
Lung Cancer
Primary: Confirm the Location Accuracy of the Local Registration Feature — 28; 19; 39; 8 Participants
Severe Hepatic Impairment · Healthy
Primary: Pharmacokinetic Parameters of MCI-186: Peak Drug Concentration (Cmax) — 347.6; 280.3 ng/mL
Intraventricular Hemorrhage of Prematurity · Complications of Prematurity
Primary: Mortality Before Hospital Discharge — 11 Participants
Multiple Sclerosis · Gait Disorders, Neurologic
Primary: Dropout Rate — 0 Participants
Healthy Individuals
Primary: Thoracic Mobility — 2.87; 2.78; 3.47; 2.86 cm — p=0.05
Asthma
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) — 64; 6 Participants
Cataract
Primary: Percentage of Eyes With Best Corrected Distance Visual Acuity (BCDVA) of 20/20 or Better at Month 6 — 87.1; 87.4 percentage of eyes